Sarcopenia Prevalence and Risk Factors among Japanese Community Dwelling Older Adults Living in a Snow-Covered City According to EWGSOP2

Ya Su, Kengo Hirayama, Tian-Fang Han, Miku Izutsu, Michiko Yuki, Ya Su, Kengo Hirayama, Tian-Fang Han, Miku Izutsu, Michiko Yuki

Abstract

Sarcopenia is a common problem among the elderly worldwide. Muscle mass can decrease with aging and decreased physical activity may occur. However, the sarcopenia prevalence among community dwelling older adults living in snow-covered cities remains largely unknown. Therefore, we evaluated the prevalence of and risk factors for sarcopenia in this population aged 65 years or older according to the definitions and diagnoses of the European Working Group on Sarcopenia in Older People-2 from two welfare centers in Sapporo, Hokkaido, Japan. The demographic characteristics, nutrition, and depression status of 310 participants were assessed using a standardized questionnaire. All participants were assessed for grip strength. Skeletal muscle index, body mass index (BMI), and total body water (TBW) were measured using bioelectrical impedance analysis. The overall sarcopenia prevalence in the study population was 8.1%. Multivariate analysis revealed that diabetes and taking more than four drugs per day were independently associated with sarcopenia (adjusted odds ratio (OR) = 3.66, 95% confidence interval (CI) = 1.06⁻12.61; OR = 2.66, CI = 1.05⁻6.77, respectively). BMI and TBW were negatively associated with sarcopenia. Sarcopenia prevalence was low in community dwelling older adults living in the snow-covered city. It is indicated that welfare center exercise may be a good intervention for the prevention of sarcopenia. Moreover, the management of diabetes, medication, and nutrition is necessary for sarcopenia prevention in community dwelling older adults.

Keywords: EWGSOP2; community dwelling; diabetes; prevalence; sarcopenia; snow.

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The Mini Nutritional Assessment Short Form (MNA-SF) scores for each sex and age group. *: MNA-SF scores showed significant differences for each sex in the 85–91-year age group.
Figure 2
Figure 2
The prevalence of sarcopenia for each sex and each age group.

References

    1. Cruz-Jentoft A.J., Bahat G., Bauer J., Boirie Y., Bruyère O., Cederholm T., Cooper C., Landi F., Rolland Y., Sayer A.A., et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 2018;39:412–423. doi: 10.1093/ageing/afq034.
    1. Landi F., Liperoti R., Russo A., Giovannini S., Tosato M., Capoluongo E., Bernabei R., Onder G. Sarcopenia as a risk factor for falls in elderly individuals: Results from the ilSIRENTE study. Clin. Nutr. 2012;31:652–658. doi: 10.1016/j.clnu.2012.02.007.
    1. Go S.W., Cha Y.H., Lee J.A., Park H.S. Association between sarcopenia, bone density, and health-related quality of life in Korean men. Korean J. Fam. Med. 2013;34:281–288. doi: 10.4082/kjfm.2013.34.4.281.
    1. Nipp R.D., Fuchs G., El-Jawahri A., Mario J., Troschel F.M., Greer J.A., Gallagher E.R., Jackson V.A., Kambadakone A., Hong T.S., et al. Sarcopenia is associated with quality of life and depression in patients with advanced cancer. Oncologist. 2018;23:97–104. doi: 10.1634/theoncologist.2017-0255.
    1. Wang H., Hai S., Liu Y., Cao L., Liu Y., Liu P., Zhou J., Yang Y., Dong B. Association between depressive symptoms and sarcopenia in older Chinese community-dwelling individuals. Clin. Interv. Aging. 2018;13:1605–1611. doi: 10.2147/CIA.S173146.
    1. Trierweiler H., Kisielewicz G., Jonasson T.H., Petterle R.R., Moreira C.A., Borba V.Z.C. Sarcopenia: A chronic complication of type 2 diabetes mellitus. Diabetol. Metab. Syndr. 2018;10:25. doi: 10.1186/s13098-018-0326-5.
    1. Park S.W., Goodpaster B.H., Strotmeyer E.S., Kuller L.H., Broudeau R., Kammerer C., de Rekeneire N., Harris T.B., Schwartz A.V., Tylavsky F.A., et al. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes the health, aging, and body composition study. Diabetes Care. 2007;3:1507–1512. doi: 10.2337/dc06-2537.
    1. Koo B.K., Roh E., Yang Y.S., Moon M.K. Difference between old and young adults in contribution of β-cell function and sarcopenia in developing diabetes mellitus. Diabetes Investig. 2016;7:233–240. doi: 10.1111/jdi.12392.
    1. Brown J.C., Harhay M.O., Harhay M.N. Sarcopenia–and mortality among a population-based sample of community-dwelling older adults. J. Cachexia Sarcopenia Muscle. 2016;7:290–298. doi: 10.1002/jcsm.12073.
    1. Yamada M., Nishiguchi S., Fukutani N., Tanigawa T., Yukutake T., Kayama H., Aoyama T., Arai H. Prevalence of sarcopenia in community-dwelling Japanese older adults. J. Am. Med. Dir. Assoc. 2013;14:911–915. doi: 10.1016/j.jamda.2013.08.015.
    1. Hai S., Wang H., Cao L., Liu P., Zhou J., Yang Y., Dong B. Association between sarcopenia with lifestyle and family function among community-dwelling Chinese aged 60 years and older. BMC Geriatr. 2017;17:187. doi: 10.1186/s12877-017-0587-0.
    1. Ryu M., Jo J., Lee Y., Chung Y.S., Kim K.M., Baek W.C. Association of physical activity with sarcopenia and sarcopenic obesity in community-dwelling older adults: The Fourth Korea National Health and Nutrition Examination Survey. Age Ageing. 2013;42:734–740. doi: 10.1093/ageing/aft063.
    1. Ethgen O., Beaudart C., Buckinx F., Bruyère O., Reginster J.Y. The future prevalence of sarcopenia in Europe: A claim for public health action. Calcif. Tissue Int. 2017;100:229–234. doi: 10.1007/s00223-016-0220-9.
    1. Morley J.E., Anker S.D., von Haehling S. Prevalence, incidence, and clinical impact of sarcopenia: Facts, numbers, and epidemiology-update 2014. J. Cachexia Sarcopenia Muscle. 2014;5:253–259. doi: 10.1007/s13539-014-0161-y.
    1. Shimokata H., Ando T. Sarcopenia and its risks in epidemiological study. Jpn. J. Geriatr. 2012;49:721–725. doi: 10.3143/geriatrics.49.721.
    1. Dodds R.M., Granic A., Davies K., Kirkwood T.B., Jagger C., Sayer A.A. Prevalence and incidence of sarcopenia in the very old: Findings from the Newcastle 85+ Study. J. Cachexia Sarcopenia Muscle. 2016;8:229–237. doi: 10.1002/jcsm.12157.
    1. Konig M., Spira D., Demuth I., Steinhagen-Thiessen E., Norman K. Polypharmacy as a risk factor for clinically relevant sarcopenia: Results from the Berlin aging study II. J. Gerontol. A Biol. Sci. Med. Sci. 2017;73:117–122. doi: 10.1093/gerona/glx074.
    1. Yashida R., Shirai E. The influences of the environmental winter coldness and snow on the living activities, Health and health behaviors of adults and elderly people. Bull. Tenshi Coll. 2006;6:1–10.
    1. Arnardottir N.Y., Oskarsdottir N.D., Brychta R.J., Koster A., van Domelen D.R., Caserotti P., Eiriksdottir G., Sverrisdottir J.E., Johannsson E., Launer L.J., et al. Comparison of summer and winter objectively measured physical activity and sedentary behavior in older adults: Age, gene/environment susceptibility Reykjavik study. Int. J. Environ. Res. Public Health. 2017;14:1268. doi: 10.3390/ijerph14101268.
    1. Kaiser M., Bauer J.M., Ramsch C., Uter W., Guigoz Y., Cederholm T., Thomas D.R., Anthony P., Charlton K.E., Maggio M., et al. Validation of the Mini Nutritional Assessment Short-Form (MNA®-SF): A practical tool for identification of nutritional states. J. Nutr. Health Aging. 2009;13:782–788. doi: 10.1007/s12603-009-0214-7.
    1. Phillips M.B., Foley A.L., Barnard R., Isenring E.A., Miller M.D. Nutritional screening in community-dwelling older adults: A systematic literature review. Asia Pac. J. Clin. Nutr. 2010;19:440–449.
    1. Yesavage J.A., Sheikh J.I. Geriatric Depression Scale (GDS) recent evidence and development of a shorter version. Clin. Gerontol. 1986;5:165–173. doi: 10.1300/J018v05n01_09.
    1. Nyunt M.S., Fones C., Niti M., Ng T.P. Criterion-based validity and reliability of the Geriatric Depression Screening Scale (GDS-15) in a large validation sample of community-living Asian older adults. Aging Mental Health. 2009;13:376–382. doi: 10.1080/13607860902861027.
    1. Heymsfield S.B., Smith R., Aulet M., Bensen B., Lichtman S., Wang J., Pierson R.N., Jr. Appendicular skeletal muscle mass: Measurement by dualphoton absorptiometry. Am. J. Clin. Nutr. 1990;52:214–218. doi: 10.1093/ajcn/52.2.214.
    1. Bouchard D.R., Dionne I.J., Brochu M. Sarcopenic/obesity and physical capacity in older men and women: Data from the Nutrition as a Determinant of Successful Aging (NuAge)—The Quebec longitudinal study. Obesity (Silver Spring) 2009;17:2082–2088. doi: 10.1038/oby.2009.109.
    1. Naing L., Winn T., Rusli B.N. Practical issues in calculating the sample size for prevalence studies. Arch. Orofac. Sci. 2006;1:9–14.
    1. Uresh K., Chandrashekara S. Sample size estimation and power analysis for clinical research studies. J. Hum. Reprod. Sci. 2012;5:7–13.
    1. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., Boirie Y., Cederholm T., Landi F., Martin F.C., Michel J.P., Rolland Y., Schneider S.M., et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European working group on sarcopenia in older people. Age Ageing. 2010;39:412–423. doi: 10.1093/ageing/afq034.
    1. Fielding R.A., Vellas B., Evans W.J., Bhasin S., Morley J.E., Newman A.B., van Kan G.A., Andrieu S., Bauer J., Breuille D., et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International working group on sarcopenia. J. Am. Med. Dir. Assoc. 2011;12:249–256. doi: 10.1016/j.jamda.2011.01.003.
    1. Chen L.K., Liu L.K., Woo J., Assantachai P., Auyeung T.W., Bahyah K.S., Chou M.Y., Chen L.Y., Hsu P.S., Krairit O., et al. Sarcopenia in Asia: Consensus report of the Asian working group for sarcopenia. J. Am. Med. Dir. Assoc. 2014;15:95–101. doi: 10.1016/j.jamda.2013.11.025.
    1. Tanimoto Y., Watanabe M., Sun W., Sugiura Y., Tsuda Y., Kimura M., Hayashida I., Kusabiraki T., Kono K. Association between sarcopenia and higher-level functional capacity in daily living in community-dwelling elderly subjects in Japan. Arch. Gerontol. Geriatr. 2012;55:e9–e13. doi: 10.1016/j.archger.2012.06.015.
    1. Khongsri N., Tongsuntud S., Limampai P., Kuptniratsaikul V. The prevalence of sarcopenia and related factors in a community- dwelling elders Thai population. Osteoporos. Sarcopenia. 2016;2:110–115. doi: 10.1016/j.afos.2016.05.001.
    1. Togo F., Watanabe E., Park H., Shephard R.J., Aoyagi Y. Meteorology and the physical activity of the elderly: The Nakanojo study. Int. J. Biometeorol. 2005;50:83–89. doi: 10.1007/s00484-005-0277-z.
    1. Lee W.J., Liu L.K., Peng L.N., Lin M.H., Chen L.K., ILAS Research Group Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: Results from the I-Lan longitudinal aging study. J. Am. Med. Dir. Assoc. 2013;14:528.e1–528.e7. doi: 10.1016/j.jamda.2013.03.019.
    1. Locquet M., Beaudart C., Petermans J., Reginster J.Y., Bruyère O. EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences. J. Am. Med. Dir. Assoc. 2019 doi: 10.1016/j.jamda.2018.11.027.
    1. Kim T.N., Yang S.J., Yoo H.J., Lim K.I., Kang H.J., Song W., Seo J.A., Kim S.G., Kim N.H., Baik S.H., et al. Prevalence of sarcopenia and sarcopenic obesity in Korean adults: The Korean sarcopenic obesity study. Int. J. Obes. (Lond.) 2009;33:885–892. doi: 10.1038/ijo.2009.130.
    1. Kimura Y., Wada T., Okumiya K., Ishimoto Y., Fukutomi E., Kasahara Y., Chen W., Sakamoto R., Fujisawa M., Otsuka K., et al. Eating alone among community-dwelling Japanese elderly: Association with depression and food diversity. J. Nutr. Health Aging. 2012;16:728–731. doi: 10.1007/s12603-012-0067-3.
    1. Tanaka I., Kitamura A., Seino S., Nishi M., Tomine Y., Taniguchi Y., Yokoyama Y., Narita M., Shinkai S. Relationship between eating alone and dietary variety among urban older Japanese adults. Jpn. J. Public Health. 2018;65:744–754.
    1. Yokoyama Y., Nishi M., Murayama H., Amano H., Taniguchi Y., Nofuji Y., Narita M., Matsuo E., Seino S., Kawano Y., et al. Dietary variety and decline in lean mass and physical performance in community-dwelling older Japanese: A 4-year follow-up study. J. Nutr. Health Aging. 2017;21:11–16. doi: 10.1007/s12603-016-0726-x.
    1. Kim N.H., Kim H.S., Eun C.R., Seo J.A., Cho H.J., Kim S.G., Choi K.M., Baik S.H., Choi D.S., Park M.H., et al. Depression is associated with sarcopenia, not central obesity, in elderly Korean men. J. Am. Geriatr. Soc. 2011;59:2062–2068. doi: 10.1111/j.1532-5415.2011.03664.x.
    1. Chang K.V., Hsu T.H., Wu W.T., Huang K.C., Han D.S. Is sarcopenia associated with depression? A systematic review and meta-analysis of observational studies. Age Ageing. 2017;46:738–746. doi: 10.1093/ageing/afx094.
    1. Kim H., Hirano H., Edahiro A., Ohara Y., Watanabe Y., Kojima N., Kim M., Hosoi E., Yoshida Y., Yoshida H., et al. Sarcopenia: Prevalence and associated factors based on different suggested definitions in community-dwelling older adults. Geriatr. Gerontol. Int. 2016;16(Suppl. 1):110–122. doi: 10.1111/ggi.12723.
    1. Landi F., Liperoti R., Fusco D., Mastropaolo S., Quattrociocchi D., Proia A., Russo A., Bernabei R., Onder G. Prevalence and risk factors of sarcopenia among nursing home older residents. J. Gerontol. A Biol. Sci. Med. Sci. 2012;67:48–55. doi: 10.1093/gerona/glr035.
    1. Gao L., Jiang J., Yang M., Hao Q., Luo L., Dong B. Prevalence of sarcopenia and associated factors in Chinese community-dwelling elderly: Comparison between rural and urban areas. J. Am. Med. Dir. Assoc. 2015;16:1003.e1–1003.e6. doi: 10.1016/j.jamda.2015.07.020.
    1. Yu R., Wong M., Leung J., Lee J., Auyeung T.W., Woo J. Incidence, reversibility, risk factors and the protective effect of high body mass index against sarcopenia in community-dwelling older Chinese adults. Geriatr. Gerontol. Int. 2014;14(Suppl. 1):15–28. doi: 10.1111/ggi.12220.
    1. Listrat A., Lebret B., Louveau I., Astruc T., Bonnet M., Lefaucheur L., Picard B., Bugeon J. How muscle structure and composition influence meat and flesh quality. Sci. World J. 2016;14:3182746. doi: 10.1155/2016/3182746.
    1. Kojima T., Akishita M., Nakamura T., Nomura K., Ogawa S., Iijima K., Eto M., Ouchi Y. Association of polypharmacy with fall risk among geriatric outpatients. Geriatr. Gerontol. Int. 2011;11:438–444. doi: 10.1111/j.1447-0594.2011.00703.x.
    1. Gnjidic D., Hilmer S.N., Blyth F.M., Naganathan V., Waite L., Seibel M.J., McLachlan A.J., Cumming R.G., Handelsman D.J., Le Couteur D.G. Polypharmacy cutoff and outcomes: Five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J. Clin. Epidemiol. 2012;65:989–995. doi: 10.1016/j.jclinepi.2012.02.018.
    1. Field T.S., Gurwitz J.H., Harrold L.R., Rothschild J., DeBellis K.R., Seger A.C., Auger J.C., Garber L.A., Cadoret C., Fish L.S., et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J. Am. Geriatr. Soc. 2004;52:1349–1354. doi: 10.1111/j.1532-5415.2004.52367.x.
    1. Marcum Z.A., Amuan M.E., Hanlon J.T., Aspinall S.L., Handler S.M., Ruby C.M., Pugh M.J. Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans. J. Am. Geriatr. Soc. 2012;60:34–41. doi: 10.1111/j.1532-5415.2011.03772.x.
    1. Heuberger R.A., Caudell K. Polypharmacy and nutritional status in older adults: A cross-sectional study. Drugs Aging. 2011;28:315–323. doi: 10.2165/11587670-000000000-00000.
    1. Heseltine R., Skelton D., Kendrick D., Morris R., Griffin M., Haworth D., Masud T., Iliffe S. “Keeping Moving”: Factors associated with sedentary behaviour among older people recruited to an exercise promotion trial in general practice. BMC Fam. Pract. 2015;16:67. doi: 10.1186/s12875-015-0284-z.
    1. Kim T.N., Park M.S., Yang S.J., Yoo H.J., Kang H.J., Song W., Seo J.A., Kim S.G., Kim N.H., Baik S.H., et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: The Korean Sarcopenic Obesity Study (KSOS) Diabetes Care. 2010;33:1497–1499. doi: 10.2337/dc09-2310.
    1. Leenders M., Verdijk L.B., van der Hoeven L., Adam J.J., van Kranenburg J., Nilwik R., van Loon L.J. Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. J. Am. Med. Dir. Assoc. 2013;14:585–592. doi: 10.1016/j.jamda.2013.02.006.
    1. Wang T., Feng X., Zhou J., Gong H., Xia S., Wei Q., Hu X., Tao R., Li L., Qian F., et al. Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly. Sci. Rep. 2016;6:1–7. doi: 10.1038/srep38937.
    1. Hamasaki H., Kawashima Y., Katsuyama H., Sako A., Goto A., Yanai H. Association of handgrip strength with hospitalization, cardiovascular events, and mortality in Japanese patients with type 2 diabetes. Sci. Rep. 2017;7:1–9. doi: 10.1038/s41598-017-07438-8.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit